MAPT and Creutzfeldt Jacob disease: Rises of CSF tau levels have also been detected in Creutzfeldt-Jakob Disease (CJD), vascular dementias and after acute stroke [13, 20, 21], indicating tau to be a sensitive biomarker for neurodestruction, but unspecific for the underlying disease process.